NYSE: ANRO
Alto Neuroscience Inc Stock Ownership - Who owns Alto Neuroscience?

Insider buying vs selling

Have Alto Neuroscience Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Amit EtkinPRESIDENT AND CEO2026-03-016,227$19.69
$122.61kSell
Nicholas Conrad SmithCHIEF FINANCIAL OFFICER CBO2026-03-012,806$19.69
$55.25kSell

1 of 1

ANRO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANRO insiders and whales buy or sell their stock.

ANRO Shareholders

What type of owners hold Alto Neuroscience Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Alpha Wave Global LP10.57%3,707,757$106.30MInsider
Alpha Wave Global LP10.57%3,707,757$106.30MInstitution
Commodore Capital LP7.76%2,723,196$78.07MInstitution
Vestal Point Capital LP5.88%2,064,075$59.18MInstitution
Perceptive Advisors LLC5.73%2,009,893$57.62MInstitution
Spruce Street Capital LP3.78%1,325,210$37.99MInstitution
Vanguard Capital Management LLC3.44%1,207,025$34.61MInstitution
Franklin Resources Inc3.14%1,101,874$31.59MInstitution
Vivo Capital LLC2.95%1,035,551$29.69MInstitution
Apeiron Investment Group Ltd2.64%926,539$26.56MInsider

1 of 3

ANRO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANRO76.45%18.01%Net Selling
REPL65.69%34.31%Net SellingNet Selling
ARDX42.56%57.44%Net SellingNet Selling
ODTX0.00%25.85%Net BuyingNet Buying
SANA53.53%46.47%Net Selling

Alto Neuroscience Stock Ownership FAQ

Who owns Alto Neuroscience?

Alto Neuroscience (NYSE: ANRO) is owned by 76.45% institutional shareholders, 18.01% Alto Neuroscience insiders, and 5.54% retail investors. Alpha Wave Global LP is the largest individual Alto Neuroscience shareholder, owning 3.71M shares representing 10.57% of the company. Alpha Wave Global LP's Alto Neuroscience shares are currently valued at $106.30M.

If you're new to stock investing, here's how to buy Alto Neuroscience stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.